论文部分内容阅读
本文将217例缺血性脑血管病随机分为两组,治疗组用灯盏花和胞二磷胆碱,对照组用以往常用的维脑路通和胞二磷胆碱,对照观察疗效。结果:急性脑梗塞治疗组总有效率96.94％,与对照组相比有极显著差异(P<0.01)。根据治疗组按患病时间分布的四个亚组分析,治疗愈早疗效愈佳;短暂性脑缺血发作(TIA)治疗组痊愈率91.89％,与对照组相比有极显著差异(P<0.01)。结论:本方案经药理和临床研究均有增效价值,对治疗各期缺血性脑血管病疗效显著。
In this paper, 217 cases of ischemic cerebrovascular disease were randomly divided into two groups, the treatment group with Erigeron and Citicoline, the control group used the usual Venoruton and citicoline, the control effect observed. Results: The total effective rate of acute cerebral infarction group was 96.94%, which was significantly different from the control group (P <0.01). According to the four subgroups of the treatment group according to the diseased time distribution, the earlier the treatment, the better the curative effect. The cure rate of the TIA group was 91.89%, which was significantly different from the control group (P < 0.01). Conclusion: The pharmacological and clinical studies have synergistic value of the program, the treatment of ischemic cerebrovascular disease significant effect.